Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
February 3, 2023
Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial
July 23, 2021
Related Post
-
-
Silo Pharma Announces Expansion of Intellectual Property Portfolio
February 2, 2023
-
First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic Fibrosis
February 2, 2023
-
IDEAYA Biosciences to Participate in the 2023 Guggenheim Oncology Conference
February 1, 2023